SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-031693
Filing Date
2021-05-11
Accepted
2021-05-11 16:35:33
Documents
2
Period of Report
2021-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3624
2 POA DOCUMENT poa.txt EX-24.3_983976 3399
  Complete submission text file 0001209191-21-031693.txt   8566
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address
Dekker C. Jeffrey (Reporting) CIK: 0001546840 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 21911813